- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- TE-71 thymic epithelial cell line
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography and conjugated with Alexa Fluor? 647 under optimal conditions.
- Concentration
- 0.5 mg/ml
- Storage & Handling
- The CD326 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
IHC-F, 3D IHC?- Verified
SB - Reported in the literature, not verified in house
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. For immunohistochemistry on frozen tissue sections, a concentration range of 2.5 - 5.0 ?g/ml is suggested.?For 3D immunohistochemistry on formalin-fixed tissues, a concentration of 5.0 ?g/mL is suggested. It is recommended that the reagent be titrated for optimal performance for each application.
* Alexa Fluor? 647 has a maximum emission of 668 nm when it is excited at 633nm / 635nm.
Alexa Fluor? and Pacific Blue? are trademarks of Life Technologies Corporation.
View full statement regarding label licenses - Excitation Laser
- Red Laser (633 nm)
- Application Notes
Additional reported applications for clone G8.8 (for the relevant formats) include: immunohistochemistry of?frozen sections: acetone fixed1, with or without OCT embedding2,4, and spatial biology (IBEX)13,14.
- Additional Product Notes
Iterative Bleaching Extended multi-pleXity (IBEX) is a fluorescent imaging technique capable of highly-multiplexed spatial analysis. The method relies on cyclical bleaching of panels of fluorescent antibodies in order to image and analyze many markers over multiple cycles of staining, imaging, and, bleaching. It is a community-developed open-access method developed by the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).
- Application References
(PubMed link indicates BioLegend citation) -
- Farr A, et al. 1991. J. Histochem. Cytochem. 39:645. (FC, IHC)
- Dooley J, et al. 2005. J. Immunol. 175:4331. (FC, IHC)
- Hinterberger M, et. al. 2010. Nat. Immunol. 11:512. (FC) PubMed
- Gracz AD, et al. 2010. Am J. Physiol Gastrointest Liver Physiol. 298:590. (IHC) PubMed
- Nudel I, et al. 2011. J. Immunol. 186:891. PubMed
- Morimoto H, et al. 2012. Biol Reprod. 86:148. PubMed
- Ishii K, et al. 2012. Development. 139:1734. PubMed
- Takehashi M, et al. 2012. Biol Reprod. 86:178. PubMed
- Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
- Taguchi K, et al. 2014. Mol Cell Biol. 34:900. PubMed
- Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
- Ding X, et al. 2015. Cancer Res. 75:330. PubMed
- Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
- Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
- Product Citations
-
- Gabitova-Cornell L, et al. 2020. Cancer Cell. 38(4):567-583.e11. PubMed
- Sandovici I, et al. 2022. Dev Cell. 57:63. PubMed
- Bilate AM, et al. 2020. Immunity. 53(5):1001-1014.e20. PubMed
- Davis F, et al. 2015. Proc Natl Acad Sci U S A. 112:5827. PubMed
- Molaro A, et al. 2014. Genes Dev. 28:1544. PubMed
- Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
- Strunz M, et al. 2020. Nat Commun. 2.929861111. PubMed
- McClendon J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.04.012. PubMed
- Blijswijk J, et al. 2015. J Immunol. 194:307. PubMed
- Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
- Lin JR et al. 2018. eLife. 7 pii: e31657. PubMed
- Riemondy KA, et al. 2019. JCI Insight. 5:. PubMed
- Joshi PA, et al. 2019. Nat Commun. 10:1760. PubMed
- Burns KA, et al. 2018. Endocrinology. 159:103. PubMed
- Cheng Q, et al. 2020. Nat Nanotechnol. 0.842361111. PubMed
- Progatzky F, et al. 2021. Nature. 599:125. PubMed
- Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed
- Campbell C et al. 2018. Immunity. 48(6):1245-1257 . PubMed
- Xiong H, et al. 2021. Theranostics. 11:1594. PubMed
- Zhang J, et al. 2018. Sci Rep. 8:2373. PubMed
- Dravis C et al. 2018. Cancer cell. 34(3):466-482 . PubMed
- Madenspacher JH, et al. 2020. JCI Insight. 5:00. PubMed
- Heijden M, et al. 2016. Nat Commun. 7:10916. PubMed
- Moon S, et al. 2021. J Exp Med. 218:. PubMed
- Hegab A, et al. 2015. Stem Cell Res. 15: 109-121. PubMed
- Shaffer M, et al. 2010. PLoS One. 5:e12404. PubMed
- Kolodkin-Gal D, et al. 2021. Gut. Online ahead of print. PubMed
- Ma Z, et al. 2022. Methods Mol Biol. 2471:49. PubMed
- Tang R, et al. 2020. Elife. 9:00. PubMed
- Giraddi R, et al. 2015. Nat Commun. 6: 8487. PubMed
- Bernstock JD, et al. 2019. J Allergy Clin Immunol. 145:358. PubMed
- Wasik K, et al. 2015. Genes Dev. 29: 1403 - 1415. PubMed
- Stewart AS, et al. 2021. Am J Physiol Gastrointest Liver Physiol. 321:G588. PubMed
- Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed
- Miragaia RJ, et al. 2018. Sci Rep. 8:685. PubMed
- Satoh–Takayama N, et al. 2020. Immunity. 52(4):635-649. PubMed
- Fang Y, et al. 2022. Development. 149:. PubMed
- Liu Y, et al. 2020. Cell. 183(6):1665-1681.e18. PubMed
- Gaiser M, et al. 2012. Proc Natl Acad Sci U S A. 1.034027778. PubMed
- Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
- Bretz N, et al. 2014. Immunol Lett. 161:140. PubMed
- Giraddi RR et al. 2018. Cell reports. 24(6):1653-1666 . PubMed
- Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
- Oni TE, et al. 2020. J Exp Med. :217. PubMed
- Chung CY et al. 2019. Cell Rep. 29(2):495-510 . PubMed
- RRID
- AB_1134104 (BioLegend Cat. No. 118211) AB_1134101 (BioLegend Cat. No. 118212)